Monthly sulfadoxine/pyrimethamine-amodiaquine or dihydroartemisinin-piperaquine as malaria chemoprevention in young Kenyan children with sickle cell anemia: A randomized controlled trial
In a randomized trial, Steve M Taylor and colleagues study the effects of 3 malaria chemoprevention regimens on clinical malaria incidence, P. falciparum infection, and dactylitis among children with sickle cell anemia in Kenya.
Source: plos.org